Skip to main content
. 2000 Mar;119(3):404–411. doi: 10.1046/j.1365-2249.2000.01157.x

Table 2.

TCR Vα24 CD4CD8 double-negative (DN) T cell population in peripheral blood lymphocytes (PBL) from patients with atopic diseases

Materials Vα24+ DN T cells /PBL (%) Vβ11+α24+ DN T cells (%) NKR-P1A+α24+ DN T cells (%) NKR-P1A+ Vβ11+α24+ DN T cells (%)
Cont-1 0·24 47·2 45·2 45·8
Cont-2 0·13 44·9 51·2 43·7
Cont-3 0·17 51·0 61·7 49·4
Cont-4 0·19 60·8 62·3 59·5
Cont-5 0·21 83·3 81·4 80·1
Mean (s.d.) 0·19 (0·04) 57·4 (15·6) 60·4 (13·8) 55·7 (14·9)
A-1 0·06 9·9 15·3 7·5
A-2 0·14 12·3 11·2 8·6
A-3 0·07 8·2 14·4 7·6
A-4 0·08 7·3 11·2 6·2
A-5 0·06 11·4 12·6 8·8
A-6 0·11 7·7 9·2 6·5
A-7 0·03 5·2 21·2 4·2
A-8 0·03 8·1 10·0 6·1
A-9 0·06 9·3 9·9 6·3
Mean (s.d.) 0·07 (0·03)* 8·8 (2·1)* 12·8 (3·7)* 6·9 (1·4)*

The expression of TCR Vβ11 and NKR-P1A in peripheral blood Vα24 DN T cells from healthy subjects (cont-1 to -5) and patients with atopic diseases (A-1 to -9) was analysed by FACS using anti-CD4 peridinin chlorophyll protein (PerCP) plus anti-CD8 PerCP, anti-Vα24 biotin + streptavidin- allophycocyanin (APC), anti-Vβ11 FITC, and NKR-P1A + anti-mIgGl PE. PBL, Peripheral blood lymphocytes.

*

Significantly different from the mean value of healthy subjects, P <0·001.